BFRI
Biofrontera Inc
NASDAQ: BFRI · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.08
-1.82% today
Updated 2026-04-30
Market cap
$12.58M
P/E ratio
—
P/S ratio
0.30x
EPS (TTM)
$-1.04
Dividend yield
—
52W range
$1 – $1
Volume
0.1M
Biofrontera Inc (BFRI) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+29.0%
Last 4 quarters
Revenue YoY growth
+36.2%
Most recent quarter
EPS YoY growth
+314.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-7.1%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-14.4%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-19 | $0.50 | +398.1% | $0.87 | $0.87 | +0.2% |
| 2025-11-12 | $-0.62 | -8.8% | $1.04 | $0.89 | -14.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.10 | $0.50 | +398.1% | $17.10M | +36.2% |
| 2025-09-30 | $-0.57 | $-0.62 | -8.8% | $6.99M | -22.5% |
| 2025-06-30 | $-0.57 | $-0.57 | +0.0% | $9.03M | +15.2% |
| 2025-03-31 | $-0.29 | $-0.51 | -75.3% | $8.59M | +8.7% |
| 2024-12-31 | $-0.07 | $-0.23 | -231.4% | $12.56M | +18.5% |
| 2024-09-30 | $-0.83 | $-0.81 | +2.0% | $9.01M | +1.3% |
| 2024-06-30 | $-0.77 | $-0.05 | +93.5% | $7.84M | +34.0% |
| 2024-03-31 | $-1.17 | $-2.88 | -146.2% | $7.90M | -9.5% |
| 2023-12-31 | $-1.19 | $1.65 | +238.7% | $10.60M | — |
| 2023-09-30 | $-3.78 | $-4.64 | -22.8% | $8.90M | — |
| 2023-06-30 | $-4.61 | $-7.23 | -56.8% | $5.85M | — |
| 2023-03-31 | $-0.19 | $-0.28 | -47.4% | $8.73M | — |
Frequently asked questions
Has Biofrontera Inc beaten earnings estimates?
Biofrontera Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +29.0% over the last 4 quarters.
How does BFRI stock react to earnings?
BFRI stock has moved an average of -7.1% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Biofrontera Inc's revenue growth rate?
Biofrontera Inc reported year-over-year revenue growth of +36.2% in its most recent quarter, with EPS growing +314.7% year-over-year.